Skip to main content
KOREA UNITED PHARM INC logo

KOREA UNITED PHARM INC — Investor Relations & Filings

Ticker · 033270 ISIN · KR7033270000 KO Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 033270

About KOREA UNITED PHARM INC

https://www.kup.co.kr/main.do?lang=en_us

KOREA UNITED PHARM INC., established in 1987, is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of healthcare products. The company's portfolio includes over 200 products, with a focus on specialty prescription drugs, over-the-counter (OTC) medications, and a significant line of anticancer drugs. It specializes in developing incrementally modified drugs using advanced controlled-release formulation technologies for therapeutic areas such as circulatory and digestive systems. The company maintains a global presence, exporting its products to over 60 countries and operating international subsidiaries, including a PIC/s GMP-certified manufacturing facility in Vietnam. It emphasizes innovation through its R&D institute and utilizes a modern smart factory for high-quality production.

Recent filings

Filing Released Lang Actions
영업(잠정)실적(공정공시)
Regulatory Filings
2026-04-30 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 1% confidence The document is a Korean ‘최대주주등소유주식변동신고서’ (Major Shareholder Ownership Change Report) detailing share count changes of the company’s largest shareholder. It reports specific share purchases, pre‐ and post‐transaction holdings, and percentage ownership—which matches the definition of a Major Shareholding Notification.
2026-04-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Holdings of Specific Securities by Executives & Major Shareholders). It details insider share ownership changes by a company officer (dates, quantities, transactions). This matches a report of personal share transactions by company directors and executives, which corresponds to the 'Director’s Dealing' category (DIRS).
2026-04-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a Korean "주식등의 대량보유상황보고서(일반)" which literally translates to a major shareholding status report. It details the shareholdings, changes, special relationships, and reasons for reporting under the Capital Markets Act. This matches the definition of a Major Shareholding Notification (MRQ) rather than an annual report, press release, or other category. Therefore, it is classified as MRQ.
2026-04-10 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 1% confidence The document is titled “최대주주등소유주식변동신고서” (Report on Changes in Ownership of Shares by Major Shareholders) and details the changes in holdings of the largest shareholder and related parties, including share counts, dates, and reasons (e.g., market purchases). This fits the definition of a Major Shareholding Notification, where changes in significant ownership levels are reported. It is not an insider dealing report by a single director, nor an earnings, dividend, or proxy document.
2026-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” a regulatory filing reporting an officer’s (director’s) shareholdings and transactions (매수) in company stock. It details the insider’s specific securities ownership changes and is submitted to the Financial Services Commission and Korea Exchange. This matches the category for insider/director personal stock transaction reports, which is Director’s Dealing (DIRS).
2026-04-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.